Precision BioSciences amends employment agreements with four top executives; adds escrow for severance

PRECISION BIOSCIENCES INC

Amended agreements with CEO Michael Amoroso, CFO Alex Kelly, GC Dario Scimeca, and CRO Jeff Smith.
Changes include current base salary, target bonus, lump-sum cash severance, and change-in-control/restructuring provisions.
Cash severance and expenses must be funded in an escrow account with JPMorgan Chase; interest accrues to company.
Unused funds return to Precision BioSciences; agreements are substantively similar to prior contracts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.